Matches in SemOpenAlex for { <https://semopenalex.org/work/W2939487002> ?p ?o ?g. }
- W2939487002 endingPage "827" @default.
- W2939487002 startingPage "811" @default.
- W2939487002 abstract "Introduction: In recent years, immunotherapy for the treatment of solid cancer has emerged as a promising therapeutic alternative. Adoptive cell therapy (ACT), especially T cell-based, has been found to cause tumor regression and even cure in a percentage of treated patients. Checkpoint inhibitors further underscore the potential of the T cell compartment in the treatment of cancer. Not all patients respond to these treatments; however, many challenges remain.Areas covered: This review covers the challenges and progress in tumor antigen target identification and selection, and cell product manufacturing for T cell ACT. Tumor immune escape mechanisms and strategies to overcome those in the context of T cell ACT are also discussed.Expert opinion: The immunotherapy toolbox is rapidly expanding and improving, and the future promises further breakthroughs in the T cell ACT field. The heterogeneity of the tumor microenvironment and the multiplicity of tumor immune escape mechanisms pose formidable challenges to successful T cell immunotherapy in solid tumors, however. Individualized approaches and strategies combining treatments targeting different immunotherapeutic aspects will be needed in order to expand the applicability and improve the response rates in future." @default.
- W2939487002 created "2019-04-25" @default.
- W2939487002 creator A5006815144 @default.
- W2939487002 creator A5012837232 @default.
- W2939487002 creator A5020505899 @default.
- W2939487002 creator A5021245372 @default.
- W2939487002 creator A5044912089 @default.
- W2939487002 creator A5046093053 @default.
- W2939487002 creator A5056070577 @default.
- W2939487002 creator A5057657092 @default.
- W2939487002 creator A5073269957 @default.
- W2939487002 creator A5080055664 @default.
- W2939487002 date "2019-04-30" @default.
- W2939487002 modified "2023-09-30" @default.
- W2939487002 title "Facing the future: challenges and opportunities in adoptive T cell therapy in cancer" @default.
- W2939487002 cites W1480489408 @default.
- W2939487002 cites W1574254013 @default.
- W2939487002 cites W1575272888 @default.
- W2939487002 cites W1761214387 @default.
- W2939487002 cites W1809627231 @default.
- W2939487002 cites W1833288118 @default.
- W2939487002 cites W1900141668 @default.
- W2939487002 cites W1910012553 @default.
- W2939487002 cites W1940241680 @default.
- W2939487002 cites W1963522404 @default.
- W2939487002 cites W1965029629 @default.
- W2939487002 cites W1966542058 @default.
- W2939487002 cites W1967884480 @default.
- W2939487002 cites W1970276280 @default.
- W2939487002 cites W1970790405 @default.
- W2939487002 cites W1971298987 @default.
- W2939487002 cites W1979811833 @default.
- W2939487002 cites W1982488143 @default.
- W2939487002 cites W1982795546 @default.
- W2939487002 cites W1983517349 @default.
- W2939487002 cites W1985830305 @default.
- W2939487002 cites W1986533011 @default.
- W2939487002 cites W1989273697 @default.
- W2939487002 cites W1992949662 @default.
- W2939487002 cites W1995427893 @default.
- W2939487002 cites W1997944395 @default.
- W2939487002 cites W1998415250 @default.
- W2939487002 cites W2000297273 @default.
- W2939487002 cites W2001099920 @default.
- W2939487002 cites W2001717792 @default.
- W2939487002 cites W2003112634 @default.
- W2939487002 cites W2006626797 @default.
- W2939487002 cites W2006759360 @default.
- W2939487002 cites W2006987944 @default.
- W2939487002 cites W2011458181 @default.
- W2939487002 cites W2012222634 @default.
- W2939487002 cites W2013968350 @default.
- W2939487002 cites W2016983859 @default.
- W2939487002 cites W2017639055 @default.
- W2939487002 cites W2020312840 @default.
- W2939487002 cites W2021472146 @default.
- W2939487002 cites W2026318599 @default.
- W2939487002 cites W2029229183 @default.
- W2939487002 cites W2040866755 @default.
- W2939487002 cites W2042699075 @default.
- W2939487002 cites W2044433401 @default.
- W2939487002 cites W2046972425 @default.
- W2939487002 cites W2049447310 @default.
- W2939487002 cites W2051940153 @default.
- W2939487002 cites W2054738595 @default.
- W2939487002 cites W2058899594 @default.
- W2939487002 cites W2061952839 @default.
- W2939487002 cites W2062398277 @default.
- W2939487002 cites W2070636596 @default.
- W2939487002 cites W2070748533 @default.
- W2939487002 cites W2071966111 @default.
- W2939487002 cites W2072000048 @default.
- W2939487002 cites W2072420502 @default.
- W2939487002 cites W2076237275 @default.
- W2939487002 cites W2076948707 @default.
- W2939487002 cites W2078643379 @default.
- W2939487002 cites W2078992149 @default.
- W2939487002 cites W2079367392 @default.
- W2939487002 cites W2079696222 @default.
- W2939487002 cites W2085918473 @default.
- W2939487002 cites W2086834665 @default.
- W2939487002 cites W2089493370 @default.
- W2939487002 cites W2094377883 @default.
- W2939487002 cites W2094652659 @default.
- W2939487002 cites W2097995306 @default.
- W2939487002 cites W2103018035 @default.
- W2939487002 cites W2104347254 @default.
- W2939487002 cites W2104966044 @default.
- W2939487002 cites W2105011122 @default.
- W2939487002 cites W2105443773 @default.
- W2939487002 cites W2105459360 @default.
- W2939487002 cites W2106067112 @default.
- W2939487002 cites W2108706633 @default.
- W2939487002 cites W2119793652 @default.
- W2939487002 cites W2124446900 @default.
- W2939487002 cites W2128565827 @default.
- W2939487002 cites W2129702476 @default.
- W2939487002 cites W2132923173 @default.